1. Home
  2. UNB vs FATE Comparison

UNB vs FATE Comparison

Compare UNB & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Union Bankshares Inc.

UNB

Union Bankshares Inc.

HOLD

Current Price

$23.04

Market Cap

121.6M

Sector

Finance

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$2.10

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNB
FATE
Founded
1891
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
121.6M
125.6M
IPO Year
1999
2013

Fundamental Metrics

Financial Performance
Metric
UNB
FATE
Price
$23.04
$2.10
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
★ $5.74
AVG Volume (30 Days)
2.2K
★ 1.3M
Earning Date
10-21-2026
11-12-2026
Dividend Yield
★ 6.31%
N/A
EPS Growth
25.52
★ 29.88
EPS
★ 1.25
N/A
Revenue
N/A
★ $6,646,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$18.44
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$20.65
$0.95
52 Week High
$26.41
$3.23

Technical Indicators

Market Signals
Indicator
UNB
FATE
Relative Strength Index (RSI) 47.19 46.42
Support Level $22.89 $1.81
Resistance Level $24.16 $2.60
Average True Range (ATR) 0.36 0.14
MACD 0.03 0.01
Stochastic Oscillator 33.99 49.32

Price Performance

Historical Comparison
UNB
FATE

About UNB Union Bankshares Inc.

Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The Company has one definable business segment, Union Bank, which provides full retail, commercial, municipal banking, and wealth management and trust services throughout its 18 branch banking locations, three loan centers, and several ATMs covering northern Vermont and northern New Hampshire. In addition, it also offers fiduciary and asset management services through its Asset Management Group.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: